nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitisinone—Flutamide—AHR—pancreatic cancer	0.0488	1	CrCbGaD
Nitisinone—Keratitis—Erlotinib—pancreatic cancer	0.0171	0.0179	CcSEcCtD
Nitisinone—Septicemia—Epirubicin—pancreatic cancer	0.0162	0.017	CcSEcCtD
Nitisinone—Septicemia—Doxorubicin—pancreatic cancer	0.015	0.0158	CcSEcCtD
Nitisinone—Amenorrhoea—Tamoxifen—pancreatic cancer	0.0127	0.0134	CcSEcCtD
Nitisinone—Rash erythematous—Sunitinib—pancreatic cancer	0.0125	0.0132	CcSEcCtD
Nitisinone—Blepharitis—Fluorouracil—pancreatic cancer	0.0123	0.0129	CcSEcCtD
Nitisinone—Encephalopathy—Fluorouracil—pancreatic cancer	0.0118	0.0124	CcSEcCtD
Nitisinone—Cataract—Tamoxifen—pancreatic cancer	0.0118	0.0124	CcSEcCtD
Nitisinone—Neoplasm malignant—Sunitinib—pancreatic cancer	0.0112	0.0118	CcSEcCtD
Nitisinone—Hepatomegaly—Irinotecan—pancreatic cancer	0.0112	0.0117	CcSEcCtD
Nitisinone—Melaena—Erlotinib—pancreatic cancer	0.0108	0.0114	CcSEcCtD
Nitisinone—Respiratory failure—Sunitinib—pancreatic cancer	0.00976	0.0103	CcSEcCtD
Nitisinone—Sepsis—Tamoxifen—pancreatic cancer	0.00971	0.0102	CcSEcCtD
Nitisinone—Sepsis—Erlotinib—pancreatic cancer	0.00961	0.0101	CcSEcCtD
Nitisinone—Melaena—Sunitinib—pancreatic cancer	0.00936	0.00984	CcSEcCtD
Nitisinone—Hepatic function abnormal—Tamoxifen—pancreatic cancer	0.0093	0.00977	CcSEcCtD
Nitisinone—Neoplasm malignant—Irinotecan—pancreatic cancer	0.00925	0.00972	CcSEcCtD
Nitisinone—Hepatic failure—Tamoxifen—pancreatic cancer	0.00904	0.0095	CcSEcCtD
Nitisinone—Neoplasm malignant—Gemcitabine—pancreatic cancer	0.00901	0.00947	CcSEcCtD
Nitisinone—Hepatic failure—Erlotinib—pancreatic cancer	0.00894	0.0094	CcSEcCtD
Nitisinone—Rash maculo-papular—Sunitinib—pancreatic cancer	0.00871	0.00916	CcSEcCtD
Nitisinone—Thirst—Tamoxifen—pancreatic cancer	0.00854	0.00897	CcSEcCtD
Nitisinone—Sepsis—Sunitinib—pancreatic cancer	0.00832	0.00874	CcSEcCtD
Nitisinone—Leukocytosis—Fluorouracil—pancreatic cancer	0.00805	0.00846	CcSEcCtD
Nitisinone—Gastrointestinal haemorrhage—Erlotinib—pancreatic cancer	0.00804	0.00845	CcSEcCtD
Nitisinone—Hepatic function abnormal—Sunitinib—pancreatic cancer	0.00796	0.00837	CcSEcCtD
Nitisinone—Respiratory failure—Gemcitabine—pancreatic cancer	0.00783	0.00823	CcSEcCtD
Nitisinone—Hepatic failure—Sunitinib—pancreatic cancer	0.00774	0.00814	CcSEcCtD
Nitisinone—Dehydration—Erlotinib—pancreatic cancer	0.00747	0.00786	CcSEcCtD
Nitisinone—Dry skin—Erlotinib—pancreatic cancer	0.00737	0.00775	CcSEcCtD
Nitisinone—Hypoglycaemia—Sunitinib—pancreatic cancer	0.00713	0.0075	CcSEcCtD
Nitisinone—Rash erythematous—Docetaxel—pancreatic cancer	0.00713	0.00749	CcSEcCtD
Nitisinone—Gastritis—Erlotinib—pancreatic cancer	0.00711	0.00748	CcSEcCtD
Nitisinone—Photophobia—Fluorouracil—pancreatic cancer	0.0071	0.00746	CcSEcCtD
Nitisinone—Rash maculo-papular—Fluorouracil—pancreatic cancer	0.00687	0.00723	CcSEcCtD
Nitisinone—Sepsis—Irinotecan—pancreatic cancer	0.00685	0.0072	CcSEcCtD
Nitisinone—Bronchitis—Tamoxifen—pancreatic cancer	0.00675	0.0071	CcSEcCtD
Nitisinone—Sepsis—Gemcitabine—pancreatic cancer	0.00667	0.00702	CcSEcCtD
Nitisinone—Sepsis—Fluorouracil—pancreatic cancer	0.00656	0.0069	CcSEcCtD
Nitisinone—Dehydration—Sunitinib—pancreatic cancer	0.00647	0.0068	CcSEcCtD
Nitisinone—Hepatic function abnormal—Gemcitabine—pancreatic cancer	0.00639	0.00672	CcSEcCtD
Nitisinone—Dry skin—Sunitinib—pancreatic cancer	0.00638	0.0067	CcSEcCtD
Nitisinone—Hepatic failure—Gemcitabine—pancreatic cancer	0.00621	0.00653	CcSEcCtD
Nitisinone—Amenorrhoea—Docetaxel—pancreatic cancer	0.00621	0.00653	CcSEcCtD
Nitisinone—Dermatitis exfoliative—Irinotecan—pancreatic cancer	0.00607	0.00639	CcSEcCtD
Nitisinone—Conjunctivitis—Erlotinib—pancreatic cancer	0.00602	0.00633	CcSEcCtD
Nitisinone—Epistaxis—Erlotinib—pancreatic cancer	0.00584	0.00614	CcSEcCtD
Nitisinone—Bronchitis—Sunitinib—pancreatic cancer	0.00578	0.00608	CcSEcCtD
Nitisinone—Gastrointestinal haemorrhage—Irinotecan—pancreatic cancer	0.00573	0.00603	CcSEcCtD
Nitisinone—Keratitis—Epirubicin—pancreatic cancer	0.00568	0.00597	CcSEcCtD
Nitisinone—Haemoglobin—Tamoxifen—pancreatic cancer	0.00565	0.00594	CcSEcCtD
Nitisinone—Haemorrhage—Tamoxifen—pancreatic cancer	0.00562	0.00591	CcSEcCtD
Nitisinone—Haemoglobin—Erlotinib—pancreatic cancer	0.00559	0.00588	CcSEcCtD
Nitisinone—Haemorrhage—Erlotinib—pancreatic cancer	0.00556	0.00585	CcSEcCtD
Nitisinone—Respiratory failure—Docetaxel—pancreatic cancer	0.00556	0.00584	CcSEcCtD
Nitisinone—Gastrointestinal haemorrhage—Fluorouracil—pancreatic cancer	0.00549	0.00577	CcSEcCtD
Nitisinone—Dehydration—Irinotecan—pancreatic cancer	0.00533	0.0056	CcSEcCtD
Nitisinone—Keratitis—Doxorubicin—pancreatic cancer	0.00525	0.00552	CcSEcCtD
Nitisinone—Hepatomegaly—Epirubicin—pancreatic cancer	0.0052	0.00547	CcSEcCtD
Nitisinone—Eye disorder—Erlotinib—pancreatic cancer	0.0052	0.00546	CcSEcCtD
Nitisinone—Epistaxis—Sunitinib—pancreatic cancer	0.00506	0.00532	CcSEcCtD
Nitisinone—Dry skin—Fluorouracil—pancreatic cancer	0.00503	0.00529	CcSEcCtD
Nitisinone—Alopecia—Tamoxifen—pancreatic cancer	0.00497	0.00522	CcSEcCtD
Nitisinone—Alopecia—Erlotinib—pancreatic cancer	0.00491	0.00517	CcSEcCtD
Nitisinone—Haemoglobin—Sunitinib—pancreatic cancer	0.00484	0.00509	CcSEcCtD
Nitisinone—Haemorrhage—Sunitinib—pancreatic cancer	0.00481	0.00506	CcSEcCtD
Nitisinone—Hepatomegaly—Doxorubicin—pancreatic cancer	0.00481	0.00506	CcSEcCtD
Nitisinone—Rash erythematous—Epirubicin—pancreatic cancer	0.00481	0.00505	CcSEcCtD
Nitisinone—Sepsis—Docetaxel—pancreatic cancer	0.00474	0.00498	CcSEcCtD
Nitisinone—Eye disorder—Sunitinib—pancreatic cancer	0.0045	0.00473	CcSEcCtD
Nitisinone—Rash erythematous—Doxorubicin—pancreatic cancer	0.00445	0.00468	CcSEcCtD
Nitisinone—Hepatic failure—Docetaxel—pancreatic cancer	0.00441	0.00463	CcSEcCtD
Nitisinone—Leukopenia—Tamoxifen—pancreatic cancer	0.00438	0.0046	CcSEcCtD
Nitisinone—Neoplasm malignant—Epirubicin—pancreatic cancer	0.00431	0.00453	CcSEcCtD
Nitisinone—Alopecia—Sunitinib—pancreatic cancer	0.00425	0.00447	CcSEcCtD
Nitisinone—Amenorrhoea—Epirubicin—pancreatic cancer	0.00419	0.0044	CcSEcCtD
Nitisinone—Conjunctivitis—Fluorouracil—pancreatic cancer	0.00411	0.00432	CcSEcCtD
Nitisinone—Unspecified disorder of skin and subcutaneous tissue—Erlotinib—pancreatic cancer	0.00409	0.0043	CcSEcCtD
Nitisinone—Agranulocytosis—Gemcitabine—pancreatic cancer	0.00401	0.00422	CcSEcCtD
Nitisinone—Epistaxis—Fluorouracil—pancreatic cancer	0.00399	0.00419	CcSEcCtD
Nitisinone—Neoplasm malignant—Doxorubicin—pancreatic cancer	0.00399	0.00419	CcSEcCtD
Nitisinone—Haemoglobin—Irinotecan—pancreatic cancer	0.00399	0.00419	CcSEcCtD
Nitisinone—Infection—Tamoxifen—pancreatic cancer	0.00397	0.00417	CcSEcCtD
Nitisinone—Haemorrhage—Irinotecan—pancreatic cancer	0.00396	0.00417	CcSEcCtD
Nitisinone—Gastrointestinal haemorrhage—Docetaxel—pancreatic cancer	0.00396	0.00417	CcSEcCtD
Nitisinone—Agranulocytosis—Fluorouracil—pancreatic cancer	0.00395	0.00415	CcSEcCtD
Nitisinone—Infection—Erlotinib—pancreatic cancer	0.00392	0.00413	CcSEcCtD
Nitisinone—Thrombocytopenia—Tamoxifen—pancreatic cancer	0.00391	0.00411	CcSEcCtD
Nitisinone—Haemoglobin—Gemcitabine—pancreatic cancer	0.00388	0.00408	CcSEcCtD
Nitisinone—Amenorrhoea—Doxorubicin—pancreatic cancer	0.00388	0.00408	CcSEcCtD
Nitisinone—Thrombocytopenia—Erlotinib—pancreatic cancer	0.00387	0.00407	CcSEcCtD
Nitisinone—Haemorrhage—Gemcitabine—pancreatic cancer	0.00386	0.00406	CcSEcCtD
Nitisinone—Skin disorder—Erlotinib—pancreatic cancer	0.00384	0.00403	CcSEcCtD
Nitisinone—Haemoglobin—Fluorouracil—pancreatic cancer	0.00382	0.00401	CcSEcCtD
Nitisinone—Haemorrhage—Fluorouracil—pancreatic cancer	0.0038	0.00399	CcSEcCtD
Nitisinone—Leukopenia—Sunitinib—pancreatic cancer	0.00375	0.00394	CcSEcCtD
Nitisinone—Dehydration—Docetaxel—pancreatic cancer	0.00368	0.00387	CcSEcCtD
Nitisinone—Dry skin—Docetaxel—pancreatic cancer	0.00363	0.00382	CcSEcCtD
Nitisinone—Convulsion—Sunitinib—pancreatic cancer	0.00363	0.00382	CcSEcCtD
Nitisinone—Melaena—Epirubicin—pancreatic cancer	0.0036	0.00378	CcSEcCtD
Nitisinone—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—pancreatic cancer	0.00354	0.00372	CcSEcCtD
Nitisinone—Alopecia—Irinotecan—pancreatic cancer	0.0035	0.00368	CcSEcCtD
Nitisinone—Alopecia—Gemcitabine—pancreatic cancer	0.00341	0.00359	CcSEcCtD
Nitisinone—Infection—Sunitinib—pancreatic cancer	0.0034	0.00357	CcSEcCtD
Nitisinone—Alopecia—Fluorouracil—pancreatic cancer	0.00336	0.00353	CcSEcCtD
Nitisinone—Thrombocytopenia—Sunitinib—pancreatic cancer	0.00335	0.00352	CcSEcCtD
Nitisinone—Rash maculo-papular—Epirubicin—pancreatic cancer	0.00335	0.00352	CcSEcCtD
Nitisinone—Melaena—Doxorubicin—pancreatic cancer	0.00333	0.0035	CcSEcCtD
Nitisinone—Skin disorder—Sunitinib—pancreatic cancer	0.00332	0.00349	CcSEcCtD
Nitisinone—Gastrointestinal pain—Tamoxifen—pancreatic cancer	0.00326	0.00343	CcSEcCtD
Nitisinone—Gastrointestinal pain—Erlotinib—pancreatic cancer	0.00323	0.0034	CcSEcCtD
Nitisinone—Sepsis—Epirubicin—pancreatic cancer	0.00319	0.00336	CcSEcCtD
Nitisinone—Abdominal pain—Tamoxifen—pancreatic cancer	0.00316	0.00332	CcSEcCtD
Nitisinone—Abdominal pain—Erlotinib—pancreatic cancer	0.00312	0.00328	CcSEcCtD
Nitisinone—Rash maculo-papular—Doxorubicin—pancreatic cancer	0.0031	0.00325	CcSEcCtD
Nitisinone—Leukopenia—Irinotecan—pancreatic cancer	0.00309	0.00325	CcSEcCtD
Nitisinone—Hepatic function abnormal—Epirubicin—pancreatic cancer	0.00306	0.00321	CcSEcCtD
Nitisinone—Leukopenia—Gemcitabine—pancreatic cancer	0.00301	0.00316	CcSEcCtD
Nitisinone—Hepatic failure—Epirubicin—pancreatic cancer	0.00297	0.00313	CcSEcCtD
Nitisinone—Conjunctivitis—Docetaxel—pancreatic cancer	0.00297	0.00312	CcSEcCtD
Nitisinone—Eye pain—Epirubicin—pancreatic cancer	0.00296	0.00311	CcSEcCtD
Nitisinone—Leukopenia—Fluorouracil—pancreatic cancer	0.00296	0.00311	CcSEcCtD
Nitisinone—Sepsis—Doxorubicin—pancreatic cancer	0.00296	0.00311	CcSEcCtD
Nitisinone—Epistaxis—Docetaxel—pancreatic cancer	0.00288	0.00303	CcSEcCtD
Nitisinone—Convulsion—Fluorouracil—pancreatic cancer	0.00286	0.00301	CcSEcCtD
Nitisinone—Agranulocytosis—Docetaxel—pancreatic cancer	0.00285	0.003	CcSEcCtD
Nitisinone—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.00284	0.00299	CcSEcCtD
Nitisinone—Dermatitis exfoliative—Epirubicin—pancreatic cancer	0.00283	0.00298	CcSEcCtD
Nitisinone—Hepatic function abnormal—Doxorubicin—pancreatic cancer	0.00283	0.00297	CcSEcCtD
Nitisinone—Pruritus—Tamoxifen—pancreatic cancer	0.00282	0.00297	CcSEcCtD
Nitisinone—Infection—Irinotecan—pancreatic cancer	0.0028	0.00294	CcSEcCtD
Nitisinone—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.0028	0.00294	CcSEcCtD
Nitisinone—Pruritus—Erlotinib—pancreatic cancer	0.00279	0.00294	CcSEcCtD
Nitisinone—Thrombocytopenia—Irinotecan—pancreatic cancer	0.00276	0.0029	CcSEcCtD
Nitisinone—Haemoglobin—Docetaxel—pancreatic cancer	0.00275	0.0029	CcSEcCtD
Nitisinone—Hepatic failure—Doxorubicin—pancreatic cancer	0.00275	0.00289	CcSEcCtD
Nitisinone—Haemorrhage—Docetaxel—pancreatic cancer	0.00274	0.00288	CcSEcCtD
Nitisinone—Eye pain—Doxorubicin—pancreatic cancer	0.00274	0.00288	CcSEcCtD
Nitisinone—Hypoglycaemia—Epirubicin—pancreatic cancer	0.00274	0.00288	CcSEcCtD
Nitisinone—Diarrhoea—Tamoxifen—pancreatic cancer	0.00273	0.00287	CcSEcCtD
Nitisinone—Infection—Gemcitabine—pancreatic cancer	0.00273	0.00287	CcSEcCtD
Nitisinone—Abdominal pain—Sunitinib—pancreatic cancer	0.0027	0.00284	CcSEcCtD
Nitisinone—Diarrhoea—Erlotinib—pancreatic cancer	0.0027	0.00284	CcSEcCtD
Nitisinone—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.00269	0.00282	CcSEcCtD
Nitisinone—Infection—Fluorouracil—pancreatic cancer	0.00268	0.00282	CcSEcCtD
Nitisinone—Gastrointestinal haemorrhage—Epirubicin—pancreatic cancer	0.00267	0.00281	CcSEcCtD
Nitisinone—Skin disorder—Gemcitabine—pancreatic cancer	0.00267	0.0028	CcSEcCtD
Nitisinone—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.00264	0.00278	CcSEcCtD
Nitisinone—Dermatitis exfoliative—Doxorubicin—pancreatic cancer	0.00262	0.00275	CcSEcCtD
Nitisinone—Eye disorder—Docetaxel—pancreatic cancer	0.00256	0.00269	CcSEcCtD
Nitisinone—Hypoglycaemia—Doxorubicin—pancreatic cancer	0.00253	0.00266	CcSEcCtD
Nitisinone—Somnolence—Irinotecan—pancreatic cancer	0.0025	0.00263	CcSEcCtD
Nitisinone—Headache—Tamoxifen—pancreatic cancer	0.0025	0.00263	CcSEcCtD
Nitisinone—Dehydration—Epirubicin—pancreatic cancer	0.00249	0.00261	CcSEcCtD
Nitisinone—Headache—Erlotinib—pancreatic cancer	0.00247	0.0026	CcSEcCtD
Nitisinone—Gastrointestinal haemorrhage—Doxorubicin—pancreatic cancer	0.00247	0.0026	CcSEcCtD
Nitisinone—Dry skin—Epirubicin—pancreatic cancer	0.00245	0.00258	CcSEcCtD
Nitisinone—Somnolence—Gemcitabine—pancreatic cancer	0.00244	0.00256	CcSEcCtD
Nitisinone—Alopecia—Docetaxel—pancreatic cancer	0.00242	0.00255	CcSEcCtD
Nitisinone—Pruritus—Sunitinib—pancreatic cancer	0.00242	0.00254	CcSEcCtD
Nitisinone—Somnolence—Fluorouracil—pancreatic cancer	0.0024	0.00252	CcSEcCtD
Nitisinone—Gastritis—Epirubicin—pancreatic cancer	0.00236	0.00249	CcSEcCtD
Nitisinone—Diarrhoea—Sunitinib—pancreatic cancer	0.00234	0.00246	CcSEcCtD
Nitisinone—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.0023	0.00242	CcSEcCtD
Nitisinone—Dehydration—Doxorubicin—pancreatic cancer	0.0023	0.00242	CcSEcCtD
Nitisinone—Dry skin—Doxorubicin—pancreatic cancer	0.00227	0.00238	CcSEcCtD
Nitisinone—Abdominal pain—Irinotecan—pancreatic cancer	0.00223	0.00234	CcSEcCtD
Nitisinone—Bronchitis—Epirubicin—pancreatic cancer	0.00222	0.00234	CcSEcCtD
Nitisinone—Gastritis—Doxorubicin—pancreatic cancer	0.00219	0.0023	CcSEcCtD
Nitisinone—Headache—Sunitinib—pancreatic cancer	0.00214	0.00225	CcSEcCtD
Nitisinone—Leukopenia—Docetaxel—pancreatic cancer	0.00214	0.00225	CcSEcCtD
Nitisinone—Convulsion—Docetaxel—pancreatic cancer	0.00207	0.00217	CcSEcCtD
Nitisinone—Bronchitis—Doxorubicin—pancreatic cancer	0.00206	0.00216	CcSEcCtD
Nitisinone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.00202	0.00212	CcSEcCtD
Nitisinone—Conjunctivitis—Epirubicin—pancreatic cancer	0.002	0.0021	CcSEcCtD
Nitisinone—Epistaxis—Epirubicin—pancreatic cancer	0.00194	0.00204	CcSEcCtD
Nitisinone—Pruritus—Gemcitabine—pancreatic cancer	0.00194	0.00204	CcSEcCtD
Nitisinone—Infection—Docetaxel—pancreatic cancer	0.00193	0.00203	CcSEcCtD
Nitisinone—Diarrhoea—Irinotecan—pancreatic cancer	0.00193	0.00203	CcSEcCtD
Nitisinone—Agranulocytosis—Epirubicin—pancreatic cancer	0.00192	0.00202	CcSEcCtD
Nitisinone—Pruritus—Fluorouracil—pancreatic cancer	0.00191	0.00201	CcSEcCtD
Nitisinone—Thrombocytopenia—Docetaxel—pancreatic cancer	0.00191	0.002	CcSEcCtD
Nitisinone—Skin disorder—Docetaxel—pancreatic cancer	0.00189	0.00199	CcSEcCtD
Nitisinone—Diarrhoea—Gemcitabine—pancreatic cancer	0.00188	0.00197	CcSEcCtD
Nitisinone—Haemoglobin—Epirubicin—pancreatic cancer	0.00186	0.00195	CcSEcCtD
Nitisinone—Conjunctivitis—Doxorubicin—pancreatic cancer	0.00185	0.00195	CcSEcCtD
Nitisinone—Haemorrhage—Epirubicin—pancreatic cancer	0.00185	0.00194	CcSEcCtD
Nitisinone—Diarrhoea—Fluorouracil—pancreatic cancer	0.00185	0.00194	CcSEcCtD
Nitisinone—Epistaxis—Doxorubicin—pancreatic cancer	0.0018	0.00189	CcSEcCtD
Nitisinone—Agranulocytosis—Doxorubicin—pancreatic cancer	0.00178	0.00187	CcSEcCtD
Nitisinone—Headache—Irinotecan—pancreatic cancer	0.00176	0.00186	CcSEcCtD
Nitisinone—Somnolence—Docetaxel—pancreatic cancer	0.00173	0.00182	CcSEcCtD
Nitisinone—Eye disorder—Epirubicin—pancreatic cancer	0.00173	0.00182	CcSEcCtD
Nitisinone—Haemoglobin—Doxorubicin—pancreatic cancer	0.00172	0.00181	CcSEcCtD
Nitisinone—Headache—Gemcitabine—pancreatic cancer	0.00172	0.00181	CcSEcCtD
Nitisinone—Haemorrhage—Doxorubicin—pancreatic cancer	0.00171	0.0018	CcSEcCtD
Nitisinone—Headache—Fluorouracil—pancreatic cancer	0.00169	0.00178	CcSEcCtD
Nitisinone—Alopecia—Epirubicin—pancreatic cancer	0.00163	0.00172	CcSEcCtD
Nitisinone—Eye disorder—Doxorubicin—pancreatic cancer	0.0016	0.00168	CcSEcCtD
Nitisinone—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.00159	0.00167	CcSEcCtD
Nitisinone—Tension—Epirubicin—pancreatic cancer	0.00158	0.00166	CcSEcCtD
Nitisinone—Nervousness—Epirubicin—pancreatic cancer	0.00156	0.00164	CcSEcCtD
Nitisinone—Abdominal pain—Docetaxel—pancreatic cancer	0.00154	0.00162	CcSEcCtD
Nitisinone—Alopecia—Doxorubicin—pancreatic cancer	0.00151	0.00159	CcSEcCtD
Nitisinone—Agitation—Epirubicin—pancreatic cancer	0.00148	0.00155	CcSEcCtD
Nitisinone—Tension—Doxorubicin—pancreatic cancer	0.00146	0.00154	CcSEcCtD
Nitisinone—Nervousness—Doxorubicin—pancreatic cancer	0.00145	0.00152	CcSEcCtD
Nitisinone—Leukopenia—Epirubicin—pancreatic cancer	0.00144	0.00151	CcSEcCtD
Nitisinone—Convulsion—Epirubicin—pancreatic cancer	0.00139	0.00147	CcSEcCtD
Nitisinone—Pruritus—Docetaxel—pancreatic cancer	0.00138	0.00145	CcSEcCtD
Nitisinone—Agitation—Doxorubicin—pancreatic cancer	0.00137	0.00144	CcSEcCtD
Nitisinone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.00136	0.00143	CcSEcCtD
Nitisinone—Leukopenia—Doxorubicin—pancreatic cancer	0.00133	0.0014	CcSEcCtD
Nitisinone—Diarrhoea—Docetaxel—pancreatic cancer	0.00133	0.0014	CcSEcCtD
Nitisinone—Infection—Epirubicin—pancreatic cancer	0.0013	0.00137	CcSEcCtD
Nitisinone—Convulsion—Doxorubicin—pancreatic cancer	0.00129	0.00136	CcSEcCtD
Nitisinone—Thrombocytopenia—Epirubicin—pancreatic cancer	0.00129	0.00135	CcSEcCtD
Nitisinone—Skin disorder—Epirubicin—pancreatic cancer	0.00128	0.00134	CcSEcCtD
Nitisinone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.00126	0.00132	CcSEcCtD
Nitisinone—Headache—Docetaxel—pancreatic cancer	0.00122	0.00128	CcSEcCtD
Nitisinone—Infection—Doxorubicin—pancreatic cancer	0.00121	0.00127	CcSEcCtD
Nitisinone—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.00119	0.00125	CcSEcCtD
Nitisinone—Skin disorder—Doxorubicin—pancreatic cancer	0.00118	0.00124	CcSEcCtD
Nitisinone—Somnolence—Epirubicin—pancreatic cancer	0.00117	0.00123	CcSEcCtD
Nitisinone—Somnolence—Doxorubicin—pancreatic cancer	0.00108	0.00114	CcSEcCtD
Nitisinone—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.00107	0.00113	CcSEcCtD
Nitisinone—Abdominal pain—Epirubicin—pancreatic cancer	0.00104	0.00109	CcSEcCtD
Nitisinone—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000994	0.00104	CcSEcCtD
Nitisinone—Abdominal pain—Doxorubicin—pancreatic cancer	0.000961	0.00101	CcSEcCtD
Nitisinone—Pruritus—Epirubicin—pancreatic cancer	0.000929	0.000977	CcSEcCtD
Nitisinone—Diarrhoea—Epirubicin—pancreatic cancer	0.000899	0.000945	CcSEcCtD
Nitisinone—Pruritus—Doxorubicin—pancreatic cancer	0.00086	0.000904	CcSEcCtD
Nitisinone—Diarrhoea—Doxorubicin—pancreatic cancer	0.000831	0.000874	CcSEcCtD
Nitisinone—Headache—Epirubicin—pancreatic cancer	0.000823	0.000865	CcSEcCtD
Nitisinone—Headache—Doxorubicin—pancreatic cancer	0.000761	0.0008	CcSEcCtD
